Earlier this month, His Honour Judge Hacon (sitting as a Judge of the High Court) handed down his decision in Royalty Pharma Collection...

In a case earlier this month, the Technology and Construction Court has considered cross applications in respect of witness statements...

After two particularly high quarters in 2021, UK scaleups continued to attract funding from across the globe during the third quarter. A...

Earlier this week the CMA announced plans to carry out a market study on music streaming. The CMA is still determining the final scope of...

HM Treasury has published its latest policy paper, Greening Finance: A Roadmap to Sustainable Investing, which sets out a roadmap on...

"Utilising data within health and social care - priorities for data-sharing, delivering efficiencies, and driving research and...

"From growing cells to growing pains: navigating new obstacles in cell & gene therapy". That was the headline for the virtual Fierce...

Users and manufacturers of in vitro diagnostic devices ("IVDs") can breathe a little easier after the European Commission announced last...

On 14 October, the BIA hosted its annual Bioscience Forum event. I was very pleased to attend in person (a novelty given the past 18...

Back in 2015, Arnold J issued two practice statements confirming that, where possible, trials should be heard within 12 months of the...

On 8 October, Mellor J. handed down a judgment in the case of Teva v Bayer, holding claim 12 of Bayer's patent invalid for obviousness...

Last month I jotted down a few thoughts on the ND California judgment in Epic and Apple's dispute over in-app payments on the App Store....